Ipsen Eyes Opportunity In Rare Liver Diseases With Albireo Buy

Stumping Up Over $950m Upfront

 
• By Kevin Grogan
  
Ipsen
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business